Document is current

Article History

Received: 23 February 2025

Accepted: 11 July 2025

First Online: 19 August 2025

Declarations

:

: PMH received travel grants from the German Center of Cardiovascular Research (DZHK) and is supported by a grant of the Faculty of Medicine, University of Hamburg, and by a grant of the German Foundation for Heart Research, and the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) –10086/1-1. DW reports personal fees from Bayer, Boehringer-Ingelheim, Berlin Chemie, Astra Zeneca, Biotronik, and Novartis. RT reports research support from the Swiss National Science Foundation (Grant No P300PB_167803), the Swiss Heart Foundation, the Swiss Society of Cardiology, the Cardiovascular Research Foundation Basel, and speaker honoraria/consulting honoraria from Abbott, Amgen, Astra Zeneca, Roche, Siemens, Singulex, and Thermo Fisher. TZ was supported by the German Centre for Cardiovascular Research (FKZ 81Z1710101 and FKZ 81Z0710102). NS received funding grants by the German Heart Foundation and the German Research Foundation. JTN reports speaker honoraria/consulting honoraria from Abbott, PHC, Roche and Siemens. NAS reports speaker honoraria from Siemens.JTN, RT, and TZ are listed as co-inventors of an international patent on the use of a computing device to estimate the probability of myocardial infarction (International Publication Number WO2022043229A1) as well as co-founders and shareholders of the ART-EMIS Hamburg GmbH.All other authors report no conflict of interest.